Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge Robert Drain of the U.S. Bankruptcy Court in White Plains, N.Y ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid medication, the company said Tuesday. The vote puts the ...

Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription painkillers at the center of the opioid crisis. Federal regulator slammed as Massachusetts sues billionaire Sacklers for pushing OxyContin.

A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states, tribes, insurers and families favor the plan, Purdue Pharma said ...